TRPV6 (transient receptor potential vanilloid 6) has six transmembrane helices and a pore-forming loop between transmembrane segments 5 and 6 and intracellularly located amino and carboxy terminal ends. Four TRPV6 proteins co-assemble to a tetrameric channel with a single ion conducting pore. Most TRP channels are Ca²⁺ permeable, but only two, TRPV5 (synonyms ECaC1, CaT2) and TRPV6 (synonyms ECaC2, CaT1, CaT-like), are highly Ca²⁺-selective with Ca²⁺/Na⁺ ratios >100. A single aspartic residue in the pore region of TRPV5 and TRPV6 is critical for Ca²⁺ permeation which is completely abolished after replacement of this aspartate residue by alanine.
|Basic Information of TRPV6|
|Protein Name||Transient receptor potential cation channel subfamily V member 6|
|Gene Name||TRPV6, ECAC2|
|Aliases||CaT-like (CaT-L), Calcium transport protein 1 (CaT1), Epithelial calcium channel 2 (ECaC2)|
|Organism||Homo sapiens (Human)|
The TRPV5 and TRPV6 channels are both parts of transcellular Ca²⁺ transport in epithelial cells. Presumably, Ca²⁺ enters the epithelial cells via TRPV5 and TRPV6 at the apical membrane along the electrochemical gradient. Incoming Ca²⁺ regulates TRPV5/6 channels by feedback inhibition and may reach the bloodstream via Na+/Ca²⁺-exchangers and plasma membrane. TRPV6 is supposed to be responsible for Ca²⁺ uptake in the intestine. The intact TRPV6 channel is also an essential component for the Ca²⁺ uptake by the epididymal epithelium. TRPV6 is important for normal Ca²⁺ ion homeostasis in the body, including bone and skin. The channel is activated by low internal calcium level, probably including intracellular calcium store depletion, and the current exhibits an inward rectification. Several studies have demonstrated that TRPV6 is over-expressed and promotes the proliferation and invasion in many cancers, such as prostate cancer, breast and colon cancer. The contribution to carcinogenesis is unclear. However, TRPV6 can serve as a marker for cancer detection and progression and may be useful as a target for therapeutic strategies.
Fig.1 Integrated model of active epithelial Ca²⁺ transport. (Schoeber, 2007)
This article demonstrates for the first time the expression of TRPV6 in INS-1E cells and rat pancreatic beta cells and describes its role in modulating calcium signaling, beta cell proliferation, and insulin mRNA expression. In contrast, TRPV6 fails to influence insulin secretion.
This article suggests that TRPV6 and PLC-δ1 can be regarded as critical actors of Ca(2+) homeostasis in CF human bronchial epithelial cells.
This article suggests that the expression of TRPV6 is downregulated in early-stage CSCC tissues. Multivariate analyses show that TRPV6 is an independent prognostic factor for survival in early-stage CSCC patients, especially in FIGO stage I patients. Thus, TRPV6 may serve as a novel prognostic biomarker for early-stage CSCC patients.
This article reveals that TRPV6 plays an essential role in bone metabolism and is a critical regulator in osteoclasts differentiation and bone resorption.
This article suggests that TRPV6 is down-regulated in ESCC. As a predictive biomarker, TRPV6 plays a Janus-like role in predicting survival of male and female ESCC patients.
Membrane protein studies have advanced significantly over the past few years. Based on our versatile Magic™ membrane protein production platform, we could offer a series of membrane protein preparation services for worldwide customers in reconstitution forms as well as multiple active formats. Aided by our versatile Magic™ anti-membrane protein antibody discovery platform, we also provide customized anti-TRPV6 antibody development services.
During the past years, Creative Biolabs has successfully generated many functional membrane proteins for our global customers. We are happy to accelerate the development of our clients’ programs with our one-stop, custom-oriented service. For more detailed information, please feel free to contact us.